Penicillin Resistance is Not Extrapolable to Amoxicillin Resistance in Streptococcus Pneumoniae Isolated from Middle Ear Fluid in Children with Acute Otitis Media

Abstract

Objectives:

We evaluated the in vitro antibacterial activity of amoxicillin against penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae strains isolated from children with acute otitis media (AOM).

Methods:

Children more than 3 months of age with AOM who were seen in the Dr Sótero del Rio and Luis Calvo Mackenna Hospitals in Santiago, Chile, between July 1998 and December 2002 were subjected to tympanic puncture for middle ear fluid culture. The penicillin and amoxicillin susceptibilities of the S pneumoniae isolates were determined by epsilometer test (E test).

Results:

A bacterial pathogen was isolated in 432 of 543 children (80%) as follows: S pneumoniae, 40%; Haemophilus influenzae, 29%; Moraxella catarrhalis, 7%; and Streptococcus pyogenes, 4%. Penicillin-susceptible S pneumoniae strains were less common than amoxicillin-susceptible strains (60% versus 95%; odds ratio [OR], 0.08; 95% confidence interval [CI], 0.04 to 0.18). Both intermediate- and high-resistance strains were more common for penicillin (22% versus 4.5%; OR, 5.6; 95% CI, 2.5 to 12.7) than for amoxicillin (18% versus 0.5%; OR, 41.3; 95% CI, 6.0 to 821).

Conclusions:

Penicillin resistance is not extrapolable to amoxicillin among S pneumoniae strains isolated from middle ear fluid of children with AOM. Our results support the recommendation to evaluate the minimal inhibitory concentrations of penicillin-nonsusceptible S pneumoniae for amoxicillin and to continue use of this antimicrobial as a first-line antimicrobial choice for children with AOM.

Keywords

acute otitis media antibiotic resistance Streptococcus pneumoniae

Get full access to this article

View all access options for this article.

References

Teele

Klein

Rosner

. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: A prospective, cohort study. J Infect Dis 1989;160:83–94.

Dagan

Johnson

McLinn

. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J 2000;19:95–104. [Erratum in Pediatr Infect Dis J 2000;19:275.].

Rosenblüt

Santolaya

González

. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J 2001;20:501–7.

Arguedas

Dagan

Soley

. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J 2003;22:1063–8.

Hansman

Bullen

. A resistant pneumococcus. Lancet 1967;2:264–5.

Baquero

Martinez-Beltrán

Loza

. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(suppl C):31–8.

Friedland

Klugman

. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920–3.

Butler

Hofmann

Cetron

Elliott

Facklam

Breiman

. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996;174:986–93.

González

. Surveillance of antimicrobial resistance. Rev Chil Infectol 2002;19:S135–S139.

10.

Kaplan

Mason

Jr . Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann 2002;31:250–60.

11.

Piglansky

Leibovitz

Raiz

. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy off acute otitis media in children. Pediatr Infect Dis J 2003;22:405–13.

12.

American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451–65.

13.

Jacobs

. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J 2000;19(suppl):S47–S56.

14.

Dowell

Butler

Giebink

. Acute otitis media: Management and surveillance in an era of pneumococcal resistance — A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1–9. [Erratum in Pediatr Infect Dis J 1999;18:341.].

15.

Durbin

. Pneumococcal infections. Pediatr Rev 2004;25:418–24.

16.

Pérez-Trallero

Fernández-Mazarrasa

García-Rey

; Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and theirecological relationships: Results of a 1-year (1998–1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001;45:3334–40.

17.

File

Jr . Appropriate use of antimicrobials for drug-resistant pneumonia: Focus on the significance of β-lactam–resistant Streptococcus pneumoniae. Clin Infect Dis 2002;34(suppl 1):S17–S26.

18.

Viada

Sáenz

Bravo

. Experiencia con el uso de una solución de prilocaína y lidocaína (EMLA®) como anestésico en procedimientos otológicos ambulatorios. Rev Chil Otorrinolaringol Cir Cabeza Cuello 1998;58:141–6.

19.

Dagan

Abramson

Leibovitz

. Bacteriologic response to oral cephalosporins: Are established susceptibility breakpoints appropriate in the case of acute otitis media?. J Infect Dis 1997;176:1253–9.

20.

Sorensen

. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 1993;31:2097–100.

21.

National Committee for Clinical Laboratory Standards 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. MIC Interpretative Standards for Streptococcus pneumoniae M100-S13 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.

22.

Bavestrello

Cabello

Casanova

. Impacto de las medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile. Rev Med Chile 2002;130:1265–72.

23.

Valenzuela

Prat

Santolaya

. Implementación de una red nacional para la vigilancia de resistencia de agentes patógenos a antimicrobianos según síndromes clínicos. Rev Chil Infectol 2003;20:119–25.

24.

Nagai

Davies

Jacobs

Appelbaum

. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1 a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 2002;46:1273–80.

25.

Smith

Klugman

. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:2393–6.

26.

Greenberg

Speert

Mahenthiralingam

Henry

Campbell

Scheifele

; CPS/LCDC IMPACT Monitoring Network. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada. J Clin Microbiol 2002;40:68–74.

27.

Hanage

Auranen

Syrjanem

. Ability of pneumococcal serotypes and clones to cause acute otitis media: Implications for the prevention of otitis media by conjugate vaccines. Infect Immun 2004;72:76–81.

28.

Dagan

Givon-Lavi

Shkolnik

Yagupsky

Fraser

. Acute otitis media caused by an tibiotic-resistant Streptococcus pneumoniae in southern Israel: Implication for immunizing with conjugate vaccines. J Infect Dis 2000;181:1322–9.